Duodenal ulcer treatment: progress from pH to HP
Authors:
Open Access
- 1 April 1994
- journal article
- review article
- Published by Hindawi Limited in Journal of Clinical Pharmacy and Therapeutics
- Vol. 19 (2) , 73-80
Abstract
The treatment of duodenal ulcer has evolved from ineffective medical treatments through an era of surgical management, back to increasingly effective medical treatment. The advent of H2-receptor antagonists changed the outlook for ulcer patients. More recently, Helicobacter pylori, an organism which inhabits gastric mucosa exclusively, has been implicated in the pathogenesis of peptic ulcer. This bacterium is found in the stomachs of around 95% of duodenal ulcer patients. Its eradication is shown dramatically to improve the rate at which ulcers relapse. The mechanisms whereby it may cause ulceration are not established--we review current hypotheses. No method of eradication is 100% effective, and many different dual or triple therapy regimens have been tried. Metronidazole resistance is reported but its importance is not yet known. Helicobacter eradication is likely to prove a cost-effective and acceptable treatment for duodenal ulcer, and once its value has gained acceptance widespread uptake of this option is anticipated.Keywords
This publication has 34 references indexed in Scilit:
- The role and treatment of Helicobacter pylori infection in peptic ulcer disease: a review of the relationship between Helicobacter pylori infection and peptic ulcer diseaseJournal of Clinical Pharmacy and Therapeutics, 1993
- Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer.Gut, 1993
- Two‐week eradication regimen for metronidazole‐resistant Helicobacter pyloriAlimentary Pharmacology & Therapeutics, 1993
- Results of a multicentre European survey in 1991 of metronidazole resistance inHelicobacter pyloriEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- Experience with‘triple’ anti‐Helicobacter pylori eradication therapy: side effects and the importance of testing the pre‐treatment bacterial isolate for metronidazole resistanceAlimentary Pharmacology & Therapeutics, 1992
- Review article: maintenance treatment with H2‐receptor antagonists for peptic ulcer diseaseAlimentary Pharmacology & Therapeutics, 1992
- Short report: short‐term triple therapy for H. pylori‐associated duodenal ulcer diseaseAlimentary Pharmacology & Therapeutics, 1992
- Eradicating Helicobacter pyloriThe Lancet, 1992
- Triple Therapy with Sucralfate is as Effective as Triple Therapy Containing Bismuth in Eradicating Helicobacter pylori and Reducing Duodenal Ulcer Relapse RatesScandinavian Journal of Gastroenterology, 1992
- Randomised crossover trial of tripotassium dicitrato bismuthate versus high dose cimetidine for duodenal ulcers resistant to standard dose of cimetidine.Gut, 1984